CN105491883B - 细胞稳定化 - Google Patents

细胞稳定化 Download PDF

Info

Publication number
CN105491883B
CN105491883B CN201480044962.5A CN201480044962A CN105491883B CN 105491883 B CN105491883 B CN 105491883B CN 201480044962 A CN201480044962 A CN 201480044962A CN 105491883 B CN105491883 B CN 105491883B
Authority
CN
China
Prior art keywords
acid
cell
apoptosis
inhibitor
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201480044962.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN105491883A (zh
Inventor
朱蒂·穆勒-科恩
保罗·迪亚兹
罗尔夫·穆勒
瓦斯科·利贝拉尔
阿尔伯特·佩雷斯-拉达格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomatrica Inc
Original Assignee
Biomatrica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomatrica Inc filed Critical Biomatrica Inc
Publication of CN105491883A publication Critical patent/CN105491883A/zh
Application granted granted Critical
Publication of CN105491883B publication Critical patent/CN105491883B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN201480044962.5A 2013-06-13 2014-06-13 细胞稳定化 Expired - Fee Related CN105491883B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361834517P 2013-06-13 2013-06-13
US61/834,517 2013-06-13
PCT/US2014/042396 WO2015002729A2 (en) 2013-06-13 2014-06-13 Cell stabilization

Publications (2)

Publication Number Publication Date
CN105491883A CN105491883A (zh) 2016-04-13
CN105491883B true CN105491883B (zh) 2018-11-02

Family

ID=52144261

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480044962.5A Expired - Fee Related CN105491883B (zh) 2013-06-13 2014-06-13 细胞稳定化

Country Status (6)

Country Link
US (2) US20160135446A1 (enExample)
EP (2) EP3007556B1 (enExample)
JP (1) JP6604942B2 (enExample)
CN (1) CN105491883B (enExample)
CA (1) CA2915250A1 (enExample)
WO (1) WO2015002729A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
MX358640B (es) 2008-01-04 2018-08-29 Intellikine Llc Isoquinolin-1 (2h) -onas y tieno [2,3-d]pirimidin-4(3h) -onas substituidas, y metodos de uso de las mismas.
WO2012018638A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
EP2598661B1 (en) 2010-07-26 2017-09-27 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
TWI546305B (zh) 2011-01-10 2016-08-21 英菲尼提製藥股份有限公司 製備異喹啉酮之方法及異喹啉酮之固體形式
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
CN105102000B (zh) 2012-11-01 2021-10-22 无限药品公司 使用pi3激酶亚型调节剂的癌症疗法
EP3249054A1 (en) 2012-12-20 2017-11-29 Biomatrica, INC. Formulations and methods for stabilizing pcr reagents
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
EP3942931A1 (en) 2014-06-10 2022-01-26 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
CN106687580A (zh) * 2014-06-10 2017-05-17 生物马特里卡公司 在环境温度下稳定血液样品中的代谢活性细胞
ES2912965T3 (es) 2015-09-09 2022-05-30 Drawbridge Health Inc Dispositivos para la recopilación, estabilización y conservación de muestras
KR20250047404A (ko) 2015-12-08 2025-04-03 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
WO2017130756A1 (ja) * 2016-01-25 2017-08-03 学校法人 慶應義塾 小胞体ストレスを標的とする椎間板変性症に対する治療薬
KR101662975B1 (ko) * 2016-02-15 2016-10-06 서울대학교산학협력단 간암 치료 또는 예방용 조성물
EP4043475B1 (en) * 2016-03-31 2023-09-20 Berkeley Lights, Inc. Nucleic acid stabilization reagent, kits, and methods of use thereof
EP3474856B1 (en) 2016-06-24 2022-09-14 Infinity Pharmaceuticals, Inc. Combination therapies
EP3573608A1 (en) 2017-01-30 2019-12-04 Université de Liège Perk and ire-1a inhibitors against neurodevelopmental disorders
CN106963769B (zh) * 2017-03-03 2019-10-25 深圳大学 含pi3k抑制剂和perk抑制剂的药物组合物及其应用
GB201804227D0 (en) * 2018-03-16 2018-05-02 Univ Warwick Cryopreserving compositions
CN114615886A (zh) * 2019-08-29 2022-06-10 得克萨斯大学体系董事会 细胞冷冻保存培养基
CN111418579B (zh) * 2020-04-13 2021-05-18 广东华夏健康生命科学有限公司 一种脂肪组织的保存方法、脂肪组织的保存液及其制备方法
MX2022013838A (es) 2020-05-04 2023-02-22 Amgen Inc Compuestos heterociclicos como agonistas del receptor de activacion expresado en las celulas mieloides 2 y metodos de uso.
CN112210593B (zh) * 2020-11-12 2023-09-19 苏州创澜生物科技有限公司 一种冻干保护剂、可冻干的pcr试剂及其应用
CN112210594B (zh) * 2020-11-12 2023-09-19 苏州创澜生物科技有限公司 一种逆转录试剂的冻干保护剂
CN113261557A (zh) * 2021-05-28 2021-08-17 广东先康达生物科技有限公司 一种干细胞冻存液及干细胞冻存方法
CN115363016B (zh) * 2022-08-09 2023-07-18 广州明迅生物科技有限责任公司 细胞储存液及其应用
CN115777693B (zh) * 2023-02-03 2023-04-18 苏州依科赛生物科技股份有限公司 一种细胞冻存液、制备方法、应用方法及用途
WO2025240630A1 (en) * 2024-05-14 2025-11-20 Abbott Laboratories Reagent compositions for isothermal amplification of nucleic acids

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872357B1 (en) * 2000-11-22 2005-03-29 Quadrant Drug Delivery Limited Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying
CN1747971A (zh) * 2002-12-10 2006-03-15 诺瓦提斯公司 抗Nogo A的抗体(“11C7”)及其药物用途
CN101360822A (zh) * 2005-12-01 2009-02-04 生物马特里卡公司 用于生命科学的样品存储和样品管理的综合
CN102947082A (zh) * 2010-04-06 2013-02-27 金沃特公司 生物材料的稳定化的化学脱水

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US918A (en) 1838-09-14 Improvement in the mode of regulating windmills
US7037A (en) 1850-01-22 Grid-ikon slide-valve
JPH0244514B2 (ja) * 1981-09-14 1990-10-04 Nippon Oil Co Ltd Biseibutsuseikintainokoteika*zoshokuho
EP0522134A1 (en) * 1991-01-11 1993-01-13 COBE Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
US5242792A (en) * 1991-02-25 1993-09-07 The United States Of America As Represented By The Secretary Of The Navy Method for the preservation of red blood cells by lyophilization using glycerol or inositol with disaccharides
US5541290A (en) 1993-06-24 1996-07-30 Harbeson; Scott L. Optically pure calpain inhibitor compounds
JP4421681B2 (ja) * 1995-10-19 2010-02-24 バイオ‐オリジン エルエルシー 生殖細胞および胚の生存および機能を改善する方法および組成物
US6057117A (en) 1996-04-04 2000-05-02 Chiron Corporation Identification and use of selective inhibitors of glycogen synthase kinase 3
AU4920397A (en) 1996-10-11 1998-05-11 Chiron Corporation Purine inhibitors of glycogen synthase kinase 3 (gsk3)
US6821963B2 (en) 1997-07-01 2004-11-23 Warner-Lambert Company 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
US6310060B1 (en) 1998-06-24 2001-10-30 Warner-Lambert Company 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
WO1999014321A1 (en) * 1997-09-17 1999-03-25 The Walter And Eliza Hall Institute Of Medical Research Novel therapeutic molecules
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド グリコーゲンシンターゼキナーゼ３のインヒビター
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7001770B1 (en) 1998-10-15 2006-02-21 Canji, Inc. Calpain inhibitors and their applications
EP1144371B1 (en) 1999-01-13 2005-11-09 Warner-Lambert Company Llc Benzenesulphonamide derivatives and their use as mek inhibitors
GB9910580D0 (en) 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
IL149778A0 (en) * 1999-11-22 2002-11-10 Universal Preservation Technologies Inc Preservation of sensitive biological material
AU784748B2 (en) 1999-12-17 2006-06-08 Novartis Vaccines And Diagnostics, Inc. Bicyclic inhibitors of glycogen synthase kinase 3
ATE384704T1 (de) 1999-12-17 2008-02-15 Novartis Vaccines & Diagnostic Pyrazin-basierte hemmer der glycogen-synthase- kinase 3
JP3694730B2 (ja) * 2000-03-02 2005-09-14 国立大学法人京都大学 組織の冷却保存液
US7001905B2 (en) 2000-03-15 2006-02-21 Warner-Lambert Company Substituted diarylamines as MEK inhibitors
US6448245B1 (en) 2000-05-04 2002-09-10 The United States Of America As Represented By The Department Of Health And Human Services Methods of and compounds for inhibiting calpains
US6608632B2 (en) 2000-06-12 2003-08-19 Sharp Laboratories Of America, Inc. Methods and systems for improving display resolution in images using sub-pixel sampling and visual error filtering
PT1319064E (pt) 2000-07-27 2008-02-29 Novartis Vaccines & Diagnostic Polipéptidos de gsk3
US7129242B2 (en) 2000-12-06 2006-10-31 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
US20040110267A1 (en) * 2000-12-15 2004-06-10 Stratagene Room temperature stable competent cells
CA2441733A1 (en) 2001-03-29 2002-10-10 Vertex Pharmaceuticals Incorporated Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
AU2003221888B2 (en) * 2002-04-11 2008-11-06 Medimmune, Llc Preservation of bioactive materials by spray drying
GB0218800D0 (en) 2002-08-13 2002-09-18 Celltech R&D Ltd Chemical compounds
JP2007516161A (ja) 2003-06-20 2007-06-21 セルテック アール アンド ディ リミテッド キナーゼ阻害剤としてのチエノピリドン誘導体
GB0314607D0 (en) * 2003-06-23 2003-07-30 Univ Cambridge Tech Preservation method
AU2004203373A1 (en) 2003-07-25 2005-02-10 University Of Chicago Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
US7314755B2 (en) * 2003-10-15 2008-01-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Preservation of eukaryotic cells using reversible pore formation
US7795256B2 (en) 2003-10-24 2010-09-14 Ucb Pharma S.A. Thieno-pyridinone derivatives as kinase inhibitors
US20080176209A1 (en) * 2004-04-08 2008-07-24 Biomatrica, Inc. Integration of sample storage and sample management for life science
ES2243131B1 (es) 2004-05-07 2007-02-01 Consejo Sup. Investig. Cientificas Tiamidas derivadas de bifenilo como inhibidores de calpaina.
MY144232A (en) 2004-07-26 2011-08-15 Chugai Pharmaceutical Co Ltd 5-substituted-2-phenylamino benzamides as mek inhibitors
ES2255848B1 (es) 2004-12-16 2007-07-01 Consejo Superior Investig. Cientificas Derivados de isoquinolina como inhibidores de calpaina.
PT1928454E (pt) 2005-05-10 2014-12-04 Intermune Inc Derivativos da piridona para modulação do sistema de proteína quinase ativada pelo stress
WO2007002433A1 (en) 2005-06-22 2007-01-04 Plexxikon, Inc. Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors
EP1913127A2 (en) * 2005-08-11 2008-04-23 The President and Fellows of Harvard College Methods and compositions for dried cellular forms
WO2008048228A2 (en) * 2005-08-12 2008-04-24 Department Of The Army Glycine stabilized lyophilized plasma
EP1934174B1 (en) 2005-10-07 2011-04-06 Exelixis, Inc. Azetidines as mek inhibitors for the treatment of proliferative diseases
GB0601962D0 (en) 2006-01-31 2006-03-15 Ucb Sa Therapeutic agents
US8372861B2 (en) 2006-02-27 2013-02-12 The Board Of Trustees Of The Leland Stanford Junior University Inhibitors of the unfolded protein response and methods for their use
CN101454004B (zh) 2006-04-18 2013-12-04 阿迪亚生命科学公司 作为mek抑制剂的吡啶酮磺酰胺类和吡啶酮硫酰胺类
WO2008007463A1 (fr) * 2006-07-12 2008-01-17 Nippon Zenyaku Kogyo Co., Ltd. Composition de dilution et de stockage de sperme
ATE539752T1 (de) 2006-08-16 2012-01-15 Exelixis Inc Verwendung von pi3k- und mek-modulatoren bei der krebsbehandlung
ES2535166T3 (es) 2007-09-04 2015-05-06 The Scripps Research Institute Pirimidinil-aminas sustituidas como inhibidores de proteína-quinasas
US8178555B2 (en) 2008-06-24 2012-05-15 Takeda Pharmaceutical Company Limited Apoptosis signal-regulating kinase 1 inhibitors
US8492427B2 (en) 2008-07-01 2013-07-23 Genentech, Inc. Isoindolones derivatives as MEK kinase inhibitors and methods of use
WO2010046949A1 (ja) * 2008-10-22 2010-04-29 Inui Hiroaki 細胞をガラス化保存する方法および細胞のガラス化保存用容器
MX2011004175A (es) * 2008-10-22 2011-05-31 Nederlanden Staat Mezcla de conservacion y uso de la misma.
WO2010132508A2 (en) 2009-05-11 2010-11-18 Biomatrica, Inc. Compositions and methods for biological sample storage
AU2010254235B2 (en) * 2009-05-26 2015-04-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
TWI625121B (zh) 2009-07-13 2018-06-01 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
BR112012033715A2 (pt) 2010-07-02 2016-11-22 Gilead Sciences Inc inibidores de quinase de regulação de sinal de apoptose.
EP2598661B1 (en) * 2010-07-26 2017-09-27 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
WO2012018638A2 (en) * 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
US20120028933A1 (en) * 2010-07-28 2012-02-02 Baust John M Cell Culture Media Supplement and Method of Molecular Stress Control
US8664244B2 (en) 2010-09-12 2014-03-04 Advenchen Pharmaceuticals, LLC Compounds as c-Met kinase inhibitors
JP6333513B2 (ja) * 2010-11-19 2018-05-30 セーレン株式会社 細胞のガラス化保存液

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872357B1 (en) * 2000-11-22 2005-03-29 Quadrant Drug Delivery Limited Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying
CN1747971A (zh) * 2002-12-10 2006-03-15 诺瓦提斯公司 抗Nogo A的抗体(“11C7”)及其药物用途
CN101360822A (zh) * 2005-12-01 2009-02-04 生物马特里卡公司 用于生命科学的样品存储和样品管理的综合
CN102947082A (zh) * 2010-04-06 2013-02-27 金沃特公司 生物材料的稳定化的化学脱水

Also Published As

Publication number Publication date
EP3632208A1 (en) 2020-04-08
JP6604942B2 (ja) 2019-11-13
EP3007556B1 (en) 2020-05-20
CN105491883A (zh) 2016-04-13
US20160135446A1 (en) 2016-05-19
JP2016522221A (ja) 2016-07-28
WO2015002729A3 (en) 2015-05-07
EP3007556A4 (en) 2017-03-08
EP3007556A2 (en) 2016-04-20
WO2015002729A2 (en) 2015-01-08
CA2915250A1 (en) 2015-01-08
US20180184644A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
CN105491883B (zh) 细胞稳定化
Driskill et al. Control of stem cell renewal and fate by YAP and TAZ
Fenton et al. Functions and regulation of the 70 kDa ribosomal S6 kinases
Mullany et al. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo
Barr et al. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs)
Bailey et al. Synthetically scalable poly (ampholyte) which dramatically enhances cellular cryopreservation
Shaw LKB1 and AMP‐activated protein kinase control of mTOR signalling and growth
Yang et al. Molecular mechanism of size control in development and human diseases
TW201821610A (zh) 哺乳動物細胞凍結保存液
CN111655258B (zh) 用于冷冻保存的组合物和其使用方法
Zhuan et al. Antioxidant procyanidin B2 protects oocytes against cryoinjuries via mitochondria regulated cortical tension
Tan et al. The amino acid transporter SNAT2 mediates L-proline-induced differentiation of ES cells
Sun et al. The protective effect of Leucosporidium-derived ice-binding protein (LeIBP) on bovine oocytes and embryos during vitrification
Choi et al. Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells
Hodne et al. Optimized conditions for primary culture of pituitary cells from the Atlantic cod (Gadus morhua). The importance of osmolality, pCO2, and pH
Li et al. Mechanism and physiological significance of growth factor-related autophagy
Potenza et al. Cell-autonomous and non-cell-autonomous effects of Arginase 2 on cardiac aging
Drescher et al. How does hypothermia protect cardiomyocytes during cardioplegic ischemia?
Peter et al. Short-term in situ effects of prolactin and insulin on ion transport in liver and intestine of freshwater climbing perch (Anabas testudineus Bloch)
Mans et al. Burn to cycle: energetics of cell-cycle control and stem cell maintenance
Bironaite et al. Role of MAP kinases in nitric oxide induced muscle-derived adult stem cell apoptosis
Mizote et al. Activation of MTK1/MEKK4 induces cardiomyocyte death and heart failure
Morita et al. Microplate-Based Cryopreservation of Adherent-Cultured Human Cell Lines Using Amino Acids and Proteins
Alfar Cardiac molecular defects in an in vitro disease model of Vici syndrome and identification of potential therapeutic target
Darmasaputra et al. Functional consequences of somatic polyploidy in development and disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20181102

Termination date: 20210613